The present invention relates to a process for the preparation of an intravaginal matrix drug delivery device. The process comprises the steps of combining at least one therapeutic agent in a therapeutically effective amount with at least one biocompatible elastomeric polymer to form a mix； curing said mix in a mold having a shape of said intravaginal drug delivery device, to form a polymer matrix； and maturing said polymer matrix to form the intravaginal drug delivery device.The maturing step alters the release rate characteristics of a device prepared in accordance with the process of the invention.
